Synlogic Inc. - SYBX Quarterly EPS earnings growth

Synlogic, Inc. - graphic logo of issuer SYBX

Synlogic, Inc. (SYBX) and its innovative approach to developing bacterial preparations for detoxifying the body face global supply chain disruption risks and sanctions. The quarterly EPS evolution reflects this conflict of interest, where the -1853.10 level captures the current state. Against a backdrop of liquidation asset valuations and stringent crisis management, this chart confirms a critical decline in investor confidence.

Synlogic (SYBX) - Year-over-year earnings per share growth for the last twelve months from 07/04/2022 to 01/24/2026

Financial and market metric breakdowns for Synlogic, Inc. (SYBX)

- share price and consensus valuation forecast:
Stock Quotes synlogictx.com|SYBX - Analyst Forecast Prices
- issuer market value details:
Market Capitalization Synlogic Corp|SYBX - Enterprise Value
- balance sheet net asset value indicators:
Book Value per Share Synlogic|SYBX - Company Book Value|Market Value to Book Value Ratio synlogictx.com|SYBX - Company Assets
- debt and liquidity data:
Debt to Equity Synlogic, Inc.|SYBX - Long-Term Debt to Equity|Short-Term Debt to Capital synlogictx.com|SYBX - Company Total Debt Obligations|Debt to Book Capitalization Ratio Synlogic Corp|SYBX - Long-Term Debt Volume|Company Short-Term Debt Synlogic|Quick Liquidity synlogictx.com
- earnings and valuation multiples indicators:
SYBX - Net Financial Result|Future Profit Synlogic, Inc.|SYBX - Market Cap to Earnings|Future Price to Earnings synlogictx.com|SYBX - Growth-Adjusted P/E Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Synlogic Corp|SYBX - Profit before payment of interest, taxes and amortization|Earnings per share for the last twelve months Synlogic|SYBX - Net earnings per one share for the last twelve months|Quarterly EPS earnings growth synlogictx.com|SYBX - Net earnings per share change in current year|Earnings growth forecast for next year Synlogic, Inc.
Analysis of all company metrics:Synlogic, Inc.
Manufactured product of Synlogic, Inc.

This indicator measures the quarterly dynamics of earnings per share, filtering out market noise to identify the actual direction of the fundamental trend. By analyzing the quarterly EPS change, an investor assesses the effectiveness of Synlogic, Inc. (SYBX) in capitalizing on revenues amid intense pressure from biopharmaceutical behemoths and the risks posed by the emergence of more advanced synthetic drugs.

Competitors of Synlogic, Inc. (SYBX)

ASND (Ascendis Pharma) - Year-over-year net earnings per share growth for the last 12 months|MDGL: Year-over-year earnings per share growth rate for the last twelve months|CORT (Corcept) - Quarterly EPS earnings growth|Quarterly EPS earnings growth Rhythm Corp|Quarterly EPS earnings growth AKRO|Year-over-year earnings per share growth for the last twelve months MTSR (metsera.com)|Year-over-year earnings per share growth for the last twelve months MoonLake MLTX|Crinetics Pharmaceuticals, Inc. (CRNX) - Earnings per share growth in annualized terms for the last twelve months|NAMS - Year-over-year earnings per share growth for the last twelve months|SLNO: Year-over-year earnings per share growth for the last twelve months|FOLD: Quarterly EPS earnings growth|ETNB - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Agios Pharmaceuticals, Inc.|Structure Therapeutics Inc (GPCR) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months MiMedx Group (MDXG)|Year-over-year net earnings per share growth for the last 12 months Rezolute Bio RZLT|Year-over-year earnings per share growth for the last twelve months Lexicon Pharmaceuticals LXRX|Year-over-year net earnings per share change for the last twelve months mbxbio.com (MBX)|ALT: Year-over-year net earnings per share growth for the last 12 months|Earnings per share growth in annualized terms for the last twelve months Aardvark Therapeutics Inc.|Sagimet (SGMT) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months BIOA|Year-over-year earnings per share growth for the last twelve months Biomea Fusion, Inc.|Year-over-year earnings per share growth for the last twelve months QNCX|Year-over-year earnings per share growth for the last twelve months Fractyl Health (GUTS)|VTVT - Earnings per share growth in annualized terms for the last twelve months|Quarterly EPS earnings growth ATPC (Agape ATP)|Net earnings per share growth for the trailing year Pluristem Therapeutics|Lipocine Inc. - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Matinas BioPharma MTNB|SPRB: Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Galecto Inc|Year-over-year net earnings per share growth for the last 12 months CTCX|LUMO: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth ONVO|Year-over-year net earnings per share change for the last twelve months radiuspharm.com